Literature DB >> 18288702

The detrusor glycogen content of a de-obstructed bladder reflects the functional history of that bladder during PBOO.

Bas W D de Jong1, Katja P Wolffenbuttel, Jeroen R Scheepe, Dirk J Kok.   

Abstract

AIMS: To determine if detrusor glycogen content in a bladder after removal of a urethral obstruction reflects the situation of bladder dysfunction as it existed during the period of obstruction.
METHODS: The glycogen content of the detrusor was scored using a Periodic Acid Schiff's (PAS) staining. It was related to the functional history of the bladder. Bladder tissue was obtained from a guinea-pig model for posterior urethral valves where animals had been obstructed for up to 10 weeks, de-obstructed and allowed to recover for 2--8 weeks. Bladder urodynamic function had been documented with multiple measurements for the complete period of obstruction and de-obstruction.
RESULTS: The degree of glycogen deposition in a bladder after de-obstruction correlated directly with bladder function during obstruction. The strongest glycogen deposition was found in bladders having experienced the highest pressures, most instabilities, lowest compliance and highest contractility. In contrast, the bladder glycogen content was not related to the function of the bladder at the day the tissue was obtained, except for a relation between high glycogen content and continuing low compliance.
CONCLUSIONS: The glycogen content of a bladder reflects the history of bladder dysfunction, also when measured during a recovery period. This window on the functional history of a bladder may be of clinical value for picking out potential bad-responders to therapy in patients with incomplete data on bladder function during a previous period of bladder obstruction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18288702     DOI: 10.1002/nau.20567

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  6 in total

Review 1.  Obstruction-induced alterations within the urinary bladder and their role in the pathophysiology of lower urinary tract symptomatology.

Authors:  Christos Komninos; Iraklis Mitsogiannis
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

2.  Adjustable passive stiffness in mouse bladder: regulated by Rho kinase and elevated following partial bladder outlet obstruction.

Authors:  John E Speich; Jordan B Southern; Sheree Henderson; Cameron W Wilson; Adam P Klausner; Paul H Ratz
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-28

3.  Alterations in expression of HIF-1α, HIF-2α, and VEGF by idiopathic overactive bladder urothelial cells during stretch suggest role for hypoxia.

Authors:  Charlotte E Christiaansen; Yan Sun; Yu-Chao Hsu; Toby C Chai
Journal:  Urology       Date:  2011-03-12       Impact factor: 2.649

4.  Etiopathogenesis and management of bladder dysfunction in patients with posterior urethral valves.

Authors:  Joseph Thomas
Journal:  Indian J Urol       Date:  2010-10

5.  The association of adelmidrol with sodium hyaluronate displays beneficial properties against bladder changes following spinal cord injury in mice.

Authors:  Michela Campolo; Rosalba Siracusa; Marika Cordaro; Alessia Filippone; Enrico Gugliandolo; Alessio F Peritore; Daniela Impellizzeri; Rosalia Crupi; Irene Paterniti; Salvatore Cuzzocrea
Journal:  PLoS One       Date:  2019-01-17       Impact factor: 3.240

6.  Influence of sildenafil on blood oxygen saturation of the obstructed bladder.

Authors:  Jeroen R Scheepe; Arjen Amelink; Katja P Wolffenbuttel; Dirk J Kok
Journal:  BMC Urol       Date:  2014-05-29       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.